NewsRx

Search our medical news database

Herpes Simplex Virus

Immunotherapy company provides update on late-stage adjuvant programs

Published in Vaccine Weekly, January 7th, 2004

Corixa Corp. (CRXA) provided an update on two late stage potential products containing Corixa's MPL adjuvant featured during GlaxoSmithKline's (GSK) recent Research & Development Meeting with investors.

Under current license agreements, GSK incorporates Corixa's MPL adjuvant in several of its vaccines in development, including Cervarix vaccine for the prevention of human papillomavirus (HPV) infection and Simplirix vaccine for the prevention of genital herpes. In a presentation to its investors in London on December 3, 2003, GSK highlighted a variety of programs, including Cervarix and Simplirix containing Corixa's MPL adjuvant, as promising and novel treatments with...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook